Zealand Pharma aims to raise $86 million on Nasdaq

Denmark’s Zealand Pharma A/S started its previously announced initial public share offering on Nasdaq in the US on 1 August with the goal of raising $86 million for the clinical development of two of its peptide therapeutics.

Full text available to subscribers only. Click here for information on subscribing to MedNous.